The use of prescription monitoring programs to reduce opioid diversion and improve patient safety

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 27, Issue 1, 2013, Pages 4-9

  Morgan, Laura ^a   Weaver, Michael ^b   Sayeed, Zabe ^c   Orr, Ralph ^d  

^a School of Pharmacy   (United States)

^b School of Medicine   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d VIRGINIA DEPARTMENT OF HEALTH   (United States)

Author keywords

Controlled substances; Diversion; Drug; Pain management; Prescription drug abuse; Prescription monitoring programs

Indexed keywords

ANALGESIA; ARTICLE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DRUG ABUSE; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; HUMAN; OPIATE ADDICTION; PATIENT CARE; PATIENT SAFETY; PRESCRIPTION; PRESCRIPTION MONITORING PROGRAM; RISK ASSESSMENT; UTILIZATION REVIEW;

DRUG MONITORING; HUMANS; OPIOID-RELATED DISORDERS; PAIN MANAGEMENT; PATIENT SAFETY; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUG DIVERSION;

EID: 84875661587     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2012.738288     Document Type: Article

References (29)

1. Prescription drug monitoring programs: a brief overview. National Alliance for Model State Drug Laws (NAMSDL) Executive Summary, May 2012. Available at: http://www.namsdl.org/ presdrug.htm. Accessed July 16, 2012.
2. Alliance of States with Prescription Monitoring Programs. PMP legislation and operational dates. Available at: http://www. pmpalliance.org/content/pmp- legislation-operational-dates? order=field pmp legis enacted value&sort=asc. Accessed February 2012.
3. Gugelmann HM, Perrone J. Can prescription drug monitoring programs help limit opioid abuse? JAMA. 2011; 306:2258-2259.
4. PMP Center of Excellence Notes from the Field, "Nevada's Proactive PMP: The impact of unsolicited reports," 2011. Available at: http://www.pdmpexcellence.org/sites/all/pdfs/ nevada nff 10 26 11.pdf. Accessed April 23, 2012.
5. Blumenschein K, Fink JL, Freeman PR, et al. Independent evaluation of the impact and effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER). Available at: http://chfs.ky.gov/NR/rdonlyres/ 24493B2E-B1A1-4399-89AD1625953BAD43/0/KASPERE valuationFinalReport10152010.pdf. Accessed March 2012.
6. PMP Center of Excellence, "Trends in Wyoming PMP prescription history reporting: evidence for a decrease in doctor shopping?" 2010. Available at: http://www.pmpexcellence.org/ sites/all/pdfs/NFF wyoming rev 11 16 10.pdf. Accessed April 23, 2012.
7. GAO Report GAO-02-634: "Prescription drugs. State monitoring programs provide useful tool to reduce diversion," 2002. Available at: http://www.gao.gov/new.items/d02634.pdf. Accessed April 23, 2012.
8. National Association of Boards of Pharmacy. Available at: www.nabp.net. Accessed May 31, 2012.
9. Manchikanti L, Fellows B, Allinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010;13:401-435.
10. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future: National Survey Results on Drug Use, 1975-2009: Volume 1: Secondary School Students. Bethesada, MD: National Institutes of Health; 2010. NIH Publication No. 10-7584.
11. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31:506-511.
12. CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61:10-13.
13. Unintentional drug poisoning in the United States. National Center for Injury Prevention and Control. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ HomeandRecreationalSafety/pdf/poison-issue- brief.pdf. Accessed May 31, 2012.
14. Martyres RF, Clede D, Burns JM. Seeking drugs or seeking help? Escalating "doctor shopping" by young heroin users before fatal overdose. Med J Aust. 2004;180:211-214.
15. PMP Center of Excellence Notes from the Field, "Keeping Patients Safe: A Case Study on using Prescription Monitoring Program Data in an Outpatient Addictions Treatment Setting," 2011. Available at: http://www.pdmpexcellence. org/sites/all/pdfs/methadone treatment nff %203 2 11.pdf. Accessed Feb. 24, 2012.
16. Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12:747-754.
17. Kerlikowske G, Jones CM, Labelle RM, et al. Prescription drug monitoring programs-lack of effectiveness or a call to action? Pain Med. 2011;12:687-689.
18. Green TC, Zaller N, Rich J, et al. Revisiting Paulozzi et al.'s Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12:982-985.
19. Reifler LM,DrozD, Bailey JE, et al.Do prescriptionmonitoring programs impact state trends in opioid abuse/misuse? Pain Med. 2012;13:434-442.
20. Chou R, Fanciullo GJ, Fine PG, et al. American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10: 113-130.
21. PMP Center of Excellence Briefing on PMP Effectiveness, "Prescription Monitoring Programs: An effective tool in curbing the prescription drug abuse epidemic," 2012. Available at: http://www. pdmpexcellence.org/sites/all/pdfs/pmp effectiveness brief revised 3 29 12.pdf. Accessed May 31, 2012.
22. Katz N, Panas L, Kim M, et al. Usefulness of prescriptionmonitoring programs for surveillance - analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf. 2010;19:115-123.
23. Baehren DF, Marco CA, Droz DE, et al. A state-wide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2010;56:19- 23.
24. Gourlay DL, Heit HA, Almahrezi A. Universal preautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6:107-112.
25. Weaver MF, Schnoll SH. Risk assessment for opioid misuse in chronic pain treatment. Adv Pain Manage. 2008;2:68-75.
26. Weaver MF, Schnoll SH. Opioid treatment of chronic pain in patients with addiction. J Pain Palliat Care Pharmacother. 2002;16:5-26.
27. Weaver MF, Schnoll SH. Addiction issues in prescribing opioids for chronic nonmalignant pain. J Addict Med. 2007;1:2-10.
28. Weaver MF. Prescribing medications with potential for abuse. J Clin Outcomes Manage. 2009;16:171-179.
29. Alliance of States with PrescriptionMonitoring Programs. Who is authorized to request patient prescription data. 2011. Available at: http://www.pmpalliance.org/content/who-authorizedrequestpatient- prescription-data. Accessed May 24, 2012.